Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMalvern Intl Regulatory News (MLVN)

Share Price Information for Malvern Intl (MLVN)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
21.00
Ask:
24.00
Spread: 3.00 (14.286%)
Market Cap: £7.53m
MLVN Live PriceLast checked at - London Stock Exchange

Intraday Malvern Intl Share Chart

Issue of Equity

25 Sep 2018 09:24

RNS Number : 8378B
Malvern International PLC
25 September 2018
ย 

25 September 2018

ย 

MALVERN INTERNATIONAL PLC

("Malvern" or the "Company")

ย 

Conversion of Loan Notes and Issue of Equity

ย 

Malvern International plc (AIM: MLVN), the provider of educational services in the UK, Europe and Asia, announces that it has issued and allotted 4,637,960 new ordinary shares of 1p each pursuant to the conversion of ยฃ231,898 of the convertible loan notes held by KSP Investments Pte Limited ("KSP") (the "Loan Note Conversion"). Application has been made for the 4,637,960 new ordinary shares arising pursuant to the Loan Note Conversion to be admitted to trading on AIM ("Admission"). Dealings are expected to commence on 01 October 2018. Following the Loan Note Conversion there are no outstanding convertible loan notes that are held by KSP.

ย 

In accordance with the provisions of the Disclosure and Transparency Rules of the Financial Conduct Authority, the Company confirms that following this Loan Note Conversion its issued share capitalย comprises 243,426,293 Ordinary Shares of 1p each. All of the Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in Treasury. The total number of voting rights in the Company is therefore 243,426,293. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

ย 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

ย 

ENDS

ย 

Enquiries:

Malvern International PLC

www.malverninternational.com

Dr. Sam Malafeh - CEO

Navin Khattar - Non-Executive Director

Via Walbrook PR

WH Ireland Limited (NOMAD)

Nominated Adviser & Broker

Mike Coe

+44 (0) 117 945 3470

Walbrook PR

Tom Cooper / Paul McManus

+44 (0) 20 7933 8780

+44 (0) 797 122 1972

tom.cooper@walbrookpr.com

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
ย 
END
ย 
ย 
IOESEFSAIFASEEU
Date   Source Headline
9th Apr 20265:23 pmRNSDirector/PDMR Shareholding
8th Apr 20264:08 pmRNSDirector/PDMR Shareholding
31st Mar 20265:24 pmRNSResult of AGM
26th Mar 20261:43 pmRNSBoard Changes
10th Mar 20263:37 pmRNSHolding(s) in Company
10th Mar 20263:37 pmRNSHolding(s) in Company
9th Mar 20262:39 pmRNSHolding(s) in Company
9th Mar 20262:39 pmRNSHolding(s) in Company
9th Mar 20262:31 pmRNSHolding(s) in Company
6th Mar 20262:41 pmRNSNotice of AGM
5th Mar 202611:45 amRNSResult of GM and Subscription
3rd Mar 202611:17 amRNSIssue of Warrants
3rd Mar 20267:00 amRNSFinal Results
24th Feb 20267:00 amRNSResult of Retail Offer
23rd Feb 20262:04 pmRNSHolding(s) in Company
17th Feb 202612:00 pmRNSLaunch of Retail Offer
17th Feb 202611:25 amRNSResult of Placing
17th Feb 20267:00 amRNSFundraise of approximately £2.0 million
16th Feb 20267:00 amRNSUpdate on ELT operations
28th Jan 20267:00 amRNSContract win: London Metropolitan University
27th Jan 20265:19 pmRNSHolding(s) in Company
9th Oct 20254:02 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:05 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSInterim results
11th Sep 20257:00 amRNSNotice of interim results and change of year end
17th Jul 20257:00 amRNSNew five-year Partnership
30th Jun 20258:32 amRNSHolding(s) in Company
30th Jun 20257:00 amRNSHolding(s) in Company
27th Jun 202512:51 pmRNSHolding(s) in Company
27th Jun 20259:48 amRNSHolding(s) in Company
11th Jun 202511:24 amRNSResult of AGM
11th Jun 20257:00 amRNSTrading update
19th May 20257:00 amRNSNotice of AGM
16th May 20257:00 amRNSUEL: One-year contract secured
12th May 20257:00 amRNSFinal Results
17th Apr 20259:12 amRNSIssue of Warrants
6th Feb 20257:01 amRNSTrading update
6th Feb 20257:00 amRNSNew Partnership – University of Cumbria
20th Jan 20254:04 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSNew Partnership - University of Wolverhampton
28th Oct 202410:06 amRNSPCA dealing
15th Oct 20242:09 pmRNSDirector Dealing
30th Sep 20249:57 amRNSDirector Dealing
27th Sep 20243:48 pmRNSDirector Dealing
26th Sep 20247:00 amRNSInterim Results
27th Aug 20247:00 amRNSTrading update
15th Jul 20247:00 amRNSChange of Adviser
23rd May 20247:00 amRNSMigration Advisory Committee (MAC) update
20th May 202412:08 pmRNSResult of AGM
23rd Apr 20247:00 amRNSAnnual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.